During the 75th anniversary celebration, Trust President Dr. Laura Gerald offered a humble admission that it is time for the Trust to confront its history and work to repair the harm that was caused to generate their wealth. The steps taken by the Trust prove that it is well within the power of foundations and philanthropy to do better.
In a packed room filled with community leaders, leadership of the Kate B. Reynolds Charitable Trust announced the organization will no longer invest in tobacco.
This announcement comes on the organization’s 75th anniversary. Dr. Laura Gerald, the trust’s president, says that continuing to invest in tobacco contradicts its mission of serving vulnerable communities.
The Kate B. Reynolds Charitable Trust will no longer invest in tobacco. The shift was announced on Tuesday during an event in Forsyth County to celebrate its 75th anniversary.
The Kate B. Reynolds Charitable Trust, one of the largest private funders in North Carolina, has announced that it will divest its endowment from tobacco and pursue a socially responsible community-focused investment strategy in support of grantmaking centered on racial equity, health, and well-being.
The Kate B. Reynolds Charitable Trust, established at the bequest of the Winston-Salem tobacco heiress with $5 million in R.J. Reynolds Company stock in 1947, will no longer invest in tobacco and will revise its grantmaking strategies to be more socially responsible with a focus on health equity.
The Kate B. Reynolds Charitable Trust used Tuesday’s 75th anniversary celebration event to announce a clean break from tobacco-related investments.
The Kate B. Reynolds Charitable Trust announced today that it will divest from tobacco and instead commit to a socially responsible investment strategy to support community-led businesses and economic opportunities in North Carolina.
Congratulations to the Trust’s Executive Vice President Dr. Stephanie Cooper-Lewter who was recently announced as a member of the GEO’s Change Leaders in Philanthropy Fellowship (CLIPF) in the 2022-2023 cohort.